Canada Proposes Amendments to Adverse Drug Reaction Reporting

October 2009

Teresa A. Reguly

Tags:

Advertising and Marketing Food and Drug Regulatory Intellectual Property Life Sciences Pharmaceuticals

Related Expertise

Related Insights

Succeeding in the Virtual World: Access Funding to Succeed
AmacaThera, a biotechnology company focused on developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications, in its C$10.3 million Series A financing led by Lumira Ventures
Scotia Capital, UBS Securities Canada, RBC Dominion Securities and the syndicate of underwriters in DRI Healthcare Trust's US$365.3 million initial public offering of units
Québec Superior Court decision could broaden the federal government’s scope over patented drug pricing
Drug pricing and reimbursement: The role of provinces and hospitals in pharmaceutical pricing

Back